Literature DB >> 12176486

Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.

C G Fasola1, G J Netto, L W Jennings, L L Christensen, E P Molmenti, E Q Sanchez, M F Levy, R M Goldstein, G B Klintmalm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176486     DOI： 10.1016/s0041-1345(02)03023-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.

Authors:  Li Ye; Jieliang Li; Ting Zhang; Xu Wang; Yizhong Wang; Yu Zhou; Jinping Liu; Hemant K Parekh; Wenzhe Ho
Journal:  Virus Res       Date:  2012-06-21       Impact factor: 3.303

2.  Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid.

Authors:  Petra E de Ruiter; Yashna Gadjradj; Robert J de Knegt; Herold J Metselaar; Jan Nm Ijzermans; Luc Jw van der Laan
Journal:  World J Transplant       Date:  2018-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.